Chart, Financials, Historical Prices, Industry, Insider, Messages, Profile, Reports, Research, SEC Filings, more...

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen 

All Reports | Brokerage Reports | Independent Reports
All Reports (Showing 1 to 10 of 31)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
24-Nov-09New Constructs, LLCN/AVASC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10  View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: VASCULAR SOLUT -- VASC1$4  View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ATSI , BVX , ROCM , VASC -- MEDICAL SUPPLIES & EQUIPMENT3$4  View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VASCULAR SOLUTIONS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20  View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25  View Abstract
9-Nov-09Zacks Investment Research Inc.N/AVASCULAR SOLUTN (VASC) Zacks Company Snapshot1$10  View Abstract
8-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Vascular Solutions, Inc.41$65  View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25  View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25  View Abstract
Next 20

Brokerage Reports (Showing 1 to 4 of 4)
Release
Date
 [down]
Contributor Author Title Pages Price StarMine Author Rating More Info
EPS Accuracy * Portfolio Return **
21-Oct-09Caris & CompanyChris WarrenVASC - 3Q Well Done: 11% Rev. Growth8$25  View Abstract
21-Oct-09Feltl & CompanyErnest W. AndbergVASC- 3Q:09 Revenue and EPS in-line; rating and price target unchanged7$254 Stars  View Abstract
20-Oct-09Thomson StreetEventsN/AVASC - Event Transcript of Vascular Solutions, Inc. conference call, Oct. 20, 2009 / 3:30pm ET18$75  View Abstract
19-Oct-09Feltl & CompanyErnest W. AndbergVASC- 3Q:09 Preview: Revenue and EPS should be in-line6$254 Stars  View Abstract

Independent Reports (Showing 1 to 10 of 27)
Release
Date
 [down]
Contributor Author Title Pages Price More Info
24-Nov-09New Constructs, LLCN/AVASC: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings19$10View Abstract
22-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25View Abstract
20-Nov-09Ford Investor Services, Inc.N/AValue Graph: VASCULAR SOLUT -- VASC1$4View Abstract
20-Nov-09Ford Investor Services, Inc.N/AIndustry Value Graph: ATSI , BVX , ROCM , VASC -- MEDICAL SUPPLIES & EQUIPMENT3$4View Abstract
20-Nov-09Jefferson ResearchN/AJefferson Research Financial Sonar Report. A detailed analysis of the current fundamental performance of VASCULAR SOLUTIONS INC including Earnings Quality, Cash Flow Quality, Operating Efficiency, Balance Sheet Quality and Valuation.3$20View Abstract
15-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25View Abstract
9-Nov-09Zacks Investment Research Inc.N/AVASCULAR SOLUTN (VASC) Zacks Company Snapshot1$10View Abstract
8-Nov-09Wright ReportsN/AWright Investors Service Comprehensive Report for Vascular Solutions, Inc.41$65View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25View Abstract
8-Nov-09TheStreet.com RatingsN/ATheStreet.com Ratings Stock Report For: VASCULAR SOLUTIONS INC5$25View Abstract
Next 17

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.


Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.